Retinoblastoma – The Rare Eye Cancer

Retinoblastoma – The Rare Eye Cancer

Julie Scott, DNP
Julie Scott, DNP
Retinoblastoma | cancerGO

What is Retinoblastoma?

Retinoblastoma is a rare type of eye cancer that develops in the retina. The retina is the part of the eye that converts light into signals the brain uses to see. It is most commonly diagnosed in children under the age of 5, but can also occur in older people.

Risk factors

Risk factors for retinoblastoma include:

  • Having a family history
  • Inherited genetic mutations
  • Exposure to chemicals during pregnancy
  • Radiation exposure to their father

Symptoms

Symptoms of retinoblastoma can include:

  • A white pupil in photographs
  • Eye redness or pain
  • A crossed eye or lazy eye
  • Vision loss
  • Bulging of the eye
  • Bleeding in the eye

Diagnosis

Any of the above symptoms noted in children should be reported to their healthcare provider quickly. This can lead to prompt evaluation with specialized eye exams and vision tests.

Other imaging studies may be used and can include ultrasound and MRI.

For most cancers, performing a biopsy to get a tissue to test for the presence of cancer cells is done. However, this can be a very risky procedure for retinoblastoma. Because of this, it is often diagnosed by eye exams and other imaging tests.

Treatment

Treatment for retinoblastoma depends on the stage and location of cancer, the patient’s age, and overall health. Treatment options include eye-saving treatments such as:

  • Laser therapy
  • Cryotherapy (killing cancer cells by freezing them)
  • Radiation therapy
  • Chemotherapy

Other, more invasive treatment options can include surgical removal of the affected eye (enucleation) or removal of the entire eye and surrounding tissue (exenteration).

Retinoblastoma is a rare eye cancer that can affect children of all ages. Early diagnosis and treatment are essential for the best possible outcome. If you or your child have any symptoms of retinoblastoma, please see an ophthalmologist immediately.

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
What is a bone marrow transplant?
December 22, 2022

Why a Bone marrow transplant may be recommended for certain cancer patients? Acute myeloid leukemia (AML) is cancer affecting blood cells. When the myeloid cells become abnormal, these cells then grow uncontrollably. White blood cells are often affected, but red blood cells and platelets can also be affected. As these…

Julie Scott, DNP

author

Articles
Colorectal cancer treatment (CRC)
November 8, 2022

Treatment is often classified into local therapy or systemic therapy. Local therapy means that it only treats the colon or rectum, and not any other parts of the body. Systemic therapy is treatment that goes around your entire body, treating cancer cells that may be present outside of the colon.…

Julie Scott, DNP

author

Articles
Endometrial cancer: everything about screening you need to know
November 21, 2022

What is Endometrial Cancer? Endometrial cancer is a cancer of the lining of the uterus. Cancer starts when cells become abnormal and start growing out of control in this lining. Currently, no test is used to screen for endometrial cancer. Screening tests look for cancer when it is at an…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice